We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Rises As Market Takes a Dip: Key Facts
Read MoreHide Full Article
Oscar Health, Inc. (OSCR - Free Report) closed the most recent trading day at $13.23, moving +1.77% from the previous trading session. The stock's change was more than the S&P 500's daily loss of 0.61%. Elsewhere, the Dow saw a downswing of 0.26%, while the tech-heavy Nasdaq depreciated by 0.93%.
The company's stock has dropped by 5.18% in the past month, exceeding the Finance sector's loss of 5.63% and lagging the S&P 500's loss of 2.25%.
Analysts and investors alike will be keeping a close eye on the performance of Oscar Health, Inc. in its upcoming earnings disclosure. On that day, Oscar Health, Inc. is projected to report earnings of $1.21 per share, which would represent year-over-year growth of 31.52%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $4.89 billion, up 60.62% from the year-ago period.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $0.2 per share and a revenue of $18.91 billion, representing changes of +111.83% and +61.62%, respectively, from the prior year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Oscar Health, Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 168.54% higher. As of now, Oscar Health, Inc. holds a Zacks Rank of #3 (Hold).
From a valuation perspective, Oscar Health, Inc. is currently exchanging hands at a Forward P/E ratio of 63.93. For comparison, its industry has an average Forward P/E of 9.13, which means Oscar Health, Inc. is trading at a premium to the group.
The Insurance - Multi line industry is part of the Finance sector. This industry, currently bearing a Zacks Industry Rank of 147, finds itself in the bottom 40% echelons of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Oscar Health, Inc. (OSCR) Rises As Market Takes a Dip: Key Facts
Oscar Health, Inc. (OSCR - Free Report) closed the most recent trading day at $13.23, moving +1.77% from the previous trading session. The stock's change was more than the S&P 500's daily loss of 0.61%. Elsewhere, the Dow saw a downswing of 0.26%, while the tech-heavy Nasdaq depreciated by 0.93%.
The company's stock has dropped by 5.18% in the past month, exceeding the Finance sector's loss of 5.63% and lagging the S&P 500's loss of 2.25%.
Analysts and investors alike will be keeping a close eye on the performance of Oscar Health, Inc. in its upcoming earnings disclosure. On that day, Oscar Health, Inc. is projected to report earnings of $1.21 per share, which would represent year-over-year growth of 31.52%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $4.89 billion, up 60.62% from the year-ago period.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $0.2 per share and a revenue of $18.91 billion, representing changes of +111.83% and +61.62%, respectively, from the prior year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Oscar Health, Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 168.54% higher. As of now, Oscar Health, Inc. holds a Zacks Rank of #3 (Hold).
From a valuation perspective, Oscar Health, Inc. is currently exchanging hands at a Forward P/E ratio of 63.93. For comparison, its industry has an average Forward P/E of 9.13, which means Oscar Health, Inc. is trading at a premium to the group.
The Insurance - Multi line industry is part of the Finance sector. This industry, currently bearing a Zacks Industry Rank of 147, finds itself in the bottom 40% echelons of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.